All In Biotech

Drug Trial Radar · NCT02088073

Safety & Efficacy of Zirconium Silicate Dosed for 28 Days in Hyperkalemia.

Multicenter, Multi-phase, Multi-dose, Prospective, Double-blind, Placebo-controlled, Maintenance Study of Safety and Efficacy of ZS (Microporous, Fractionated, Protonated Zirconium Silicate) in Hyperkalemia.

Last checked: Nov 20, 2026Latest source record: Dec 7, 2018 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. Randomized with 258 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

258

Actual

Start

Mar 31, 2014

Primary completion

Aug 31, 2014

Study completion Jan 31, 2015

Sponsor

Lead sponsor
ZS Pharma, Inc.Industry
Sponsor type
Industry
First posted
Mar 14, 2014

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Supportive care
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

It is hypothesized that ZS is more effective than placebo control (alternative hypothesis) in maintaining mean double-blind randomized maintenance phase (DBRMP) Day 8-29 serum potassium levels (3.5 - 5.0 mmol/l, inclusive) among hyperkalemic subjects in whom normokalemia was established during the open-label acute phase versus no difference between each ZS dose (highest to lowest) versus placebo control (null hypothesis).

Conditions

  • Hyperkalemia

Interventions

  • Sodium zirconium cyclosilicateDrug

    Sodium zirconium cyclosilicate

  • PlaceboDrug

    Randomized to mimic doses of experimental drug administered once daily with breakfast for 28 days (maintenance phase)

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Mean Serum Potassium Between Maintenance Phase Study Days 8 to 29, Inclusive (MP-ITT Population).Time frame: 22 Days; Maintenance Phase Days 8 - 29, inclusive.

Locations

46 sites in 3 countries. Site status is shown where the registry gives one.

  • Site not named

    Anniston, Alabama

  • Site not named

    Huntsville, Alabama

  • Site not named

    Scottsboro, Alabama

  • Site not named

    Phoenix, Arizona

  • Site not named

    Tempe, Arizona

  • Site not named

    Hawaiian Gardens, California

  • Site not named

    Los Angeles, California

  • Site not named

    Paramount, California

  • Site not named

    Riverside, California

  • Site not named

    Atlantis, Florida

  • Site not named

    Bradenton, Florida

  • Site not named

    Brandon, Florida

  • Site not named

    Brooksville, Florida

  • Site not named

    DeLand, Florida

  • Site not named

    Edgewater, Florida

  • Site not named

    Miami, Florida

  • Site not named

    Miami Lakes, Florida

  • Site not named

    New Smyrna Beach, Florida

  • Site not named

    Ocala, Florida

  • Site not named

    Summerfield, Florida

  • Site not named

    Tampa, Florida

  • Site not named

    Winter Park, Florida

  • Site not named

    Columbus, Georgia

  • Site not named

    Decatur, Georgia

  • Site not named

    Evergreen Park, Illinois

  • Site not named

    Joliet, Illinois

  • Site not named

    Shreveport, Louisiana

  • Site not named

    Auburn, Maine

  • Site not named

    Chesterfield, Michigan

  • Site not named

    Kansas City, Missouri

  • Site not named

    Las Vegas, Nevada

  • Site not named

    Flushing, New York

  • Site not named

    Altoona, Pennsylvania

  • Site not named

    Providence, Rhode Island

  • Site not named

    Orangeburg, South Carolina

  • Site not named

    Sumter, South Carolina

  • Site not named

    Chattanooga, Tennessee

  • Site not named

    San Antonio, Texas

  • Site not named

    Gosford, New South Wales, Australia

  • Site not named

    Woolloongabba, Queensland, Australia

Showing 40 of 46 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.